Citi analyst Amit Hazan maintains Neutral on Medtronic, Inc. (NYSE: MDT).The analyst comments "Company gives color on FY19 guidance and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE